Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4 (Q74177798)
Jump to navigation
Jump to search
scientific article published on 01 January 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4 |
scientific article published on 01 January 1998 |
Statements
Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4 (English)
Kleinman EF
Campbell E
Giordano LA
Cohan VL
Jenkinson TH
Cheng JB
Shirley JT
Pettipher ER
Salter ED
Hibbs TA
DiCapua FM
1 January 1998